These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32274652)

  • 61. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.
    Ganz PA; Kwan L; Castellon SA; Oppenheim A; Bower JE; Silverman DH; Cole SW; Irwin MR; Ancoli-Israel S; Belin TR
    J Natl Cancer Inst; 2013 Jun; 105(11):791-801. PubMed ID: 23606729
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Impairment of cognitive functioning during Sunitinib or Sorafenib treatment in cancer patients: a cross sectional study.
    Mulder SF; Bertens D; Desar IM; Vissers KC; Mulders PF; Punt CJ; van Spronsen DJ; Langenhuijsen JF; Kessels RP; van Herpen CM
    BMC Cancer; 2014 Mar; 14():219. PubMed ID: 24661373
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Efficacy of Cognitive Intervention in Mild Cognitive Impairment (MCI): a Meta-Analysis of Outcomes on Neuropsychological Measures.
    Sherman DS; Mauser J; Nuno M; Sherzai D
    Neuropsychol Rev; 2017 Dec; 27(4):440-484. PubMed ID: 29282641
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature.
    Falleti MG; Sanfilippo A; Maruff P; Weih L; Phillips KA
    Brain Cogn; 2005 Oct; 59(1):60-70. PubMed ID: 15975700
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Study of Chemotherapy-Induced Cognitive Impairment in Women with Breast Cancer.
    Rodríguez Martín B; Fernández Rodríguez EJ; Rihuete Galve MI; Cruz Hernández JJ
    Int J Environ Res Public Health; 2020 Nov; 17(23):. PubMed ID: 33265966
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pupillary response: cognitive effort for breast cancer survivors.
    Myers JS; Kahya M; Mitchell M; Dai J; He J; Moon S; Hamilton K; Valla M; O'Dea A; Klemp J; Kurylo M; Akinwuntan A; Devos H
    Support Care Cancer; 2019 Mar; 27(3):1121-1128. PubMed ID: 30097791
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Chemotherapy and Cognitive Function in Breast Cancer Patients: The So-Called Chemo Brain.
    Hermelink K
    J Natl Cancer Inst Monogr; 2015 May; 2015(51):67-9. PubMed ID: 26063891
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Presurgical Identification of Patients With Glioblastoma at Risk for Cognitive Impairment at 3-Month Follow-up.
    Rijnen SJM; Butterbrod E; Rutten GM; Sitskoorn MM; Gehring K
    Neurosurgery; 2020 Nov; 87(6):1119-1129. PubMed ID: 32470985
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Age-dependent brain volume and neuropsychological changes after chemotherapy in breast cancer patients.
    Blommaert J; Schroyen G; Vandenbulcke M; Radwan A; Smeets A; Peeters R; Sleurs C; Neven P; Wildiers H; Amant F; Sunaert S; Deprez S
    Hum Brain Mapp; 2019 Dec; 40(17):4994-5010. PubMed ID: 31436005
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer.
    Wefel JS; Saleeba AK; Buzdar AU; Meyers CA
    Cancer; 2010 Jul; 116(14):3348-56. PubMed ID: 20564075
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prevalence of cognitive impairment and change in patients with breast cancer: A systematic review of longitudinal studies.
    Dijkshoorn ABC; van Stralen HE; Sloots M; Schagen SB; Visser-Meily JMA; Schepers VPM
    Psychooncology; 2021 May; 30(5):635-648. PubMed ID: 33533166
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function.
    Schagen SB; Hamburger HL; Muller MJ; Boogerd W; van Dam FS
    J Neurooncol; 2001 Jan; 51(2):159-65. PubMed ID: 11386413
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The impact of adjuvant therapy for breast cancer on cognitive function: current evidence and directions for research.
    Rugo HS; Ahles T
    Semin Oncol; 2003 Dec; 30(6):749-62. PubMed ID: 14663776
    [TBL] [Abstract][Full Text] [Related]  

  • 74. An Evaluation of DNA Methyltransferase 1 (DNMT1) Single Nucleotide Polymorphisms and Chemotherapy-Associated Cognitive Impairment: A Prospective, Longitudinal Study.
    Chan A; Yeo A; Shwe M; Tan CJ; Foo KM; Chu P; Khor CC; Ho HK
    Sci Rep; 2019 Oct; 9(1):14570. PubMed ID: 31601979
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Heterogeneous Response of Chemotherapy-Related Cognitive Decline in Patients with Breast Cancer: A Prospective Study.
    Schrauwen W; Van de Cavey J; Vingerhoets G; Vanheule S; Van den Broecke R; Denys H
    J Int Neuropsychol Soc; 2020 Sep; 26(8):806-814. PubMed ID: 32312360
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cognitive rehabilitation program to improve cognition of cancer patients treated with chemotherapy: A 3-arm randomized trial.
    Dos Santos M; Hardy-Léger I; Rigal O; Licaj I; Dauchy S; Levy C; Noal S; Segura C; Delcambre C; Allouache D; Parzy A; Barriere J; Petit T; Lange M; Capel A; Clarisse B; Grellard JM; Lefel J; Joly F
    Cancer; 2020 Dec; 126(24):5328-5336. PubMed ID: 32996583
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cognitive impairments associated with breast cancer treatments: results from a longitudinal study.
    Quesnel C; Savard J; Ivers H
    Breast Cancer Res Treat; 2009 Jul; 116(1):113-23. PubMed ID: 18629633
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cognitive deficits in Korean women treated with chemotherapy for breast cancer.
    Jung MS; Cimprich B
    Cancer Nurs; 2014; 37(3):E31-42. PubMed ID: 23945143
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cognitive Impairment in a Subset of Breast Cancer Patients After Systemic Therapy-Results From a Longitudinal Study.
    Menning S; de Ruiter MB; Kieffer JM; Agelink van Rentergem J; Veltman DJ; Fruijtier A; Oldenburg HS; Boven E; van der Meij S; Lustig V; Bos ME; Boogerd W; Reneman L; Schagen SB
    J Pain Symptom Manage; 2016 Oct; 52(4):560-569.e1. PubMed ID: 27650011
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Self-reported chemotherapy-related cognitive impairment compared with cognitive complaints following menopause.
    Vega JN; Dumas J; Newhouse PA
    Psychooncology; 2018 Sep; 27(9):2198-2205. PubMed ID: 29904964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.